| Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile SS Martin, MJ Blaha, MB Elshazly, PP Toth, PO Kwiterovich, ... Jama 310 (19), 2061-2068, 2013 | 596 | 2013 |
| Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications SS Martin, MJ Blaha, MB Elshazly, EA Brinton, PP Toth, JW McEvoy, ... Journal of the American College of Cardiology 62 (8), 732-739, 2013 | 332 | 2013 |
| Non-HDL cholesterol and triglycerides: implications for coronary atheroma progression and clinical events R Puri, SE Nissen, M Shao, MB Elshazly, Y Kataoka, SR Kapadia, ... Arteriosclerosis, thrombosis, and vascular biology 36 (11), 2220-2228, 2016 | 134 | 2016 |
| Smart wearable devices in cardiovascular care: where we are and how to move forward K Bayoumy, M Gaber, A Elshafeey, O Mhaimeed, EH Dineen, FA Marvel, ... Nature Reviews Cardiology 18 (8), 581-599, 2021 | 95 | 2021 |
| Non–high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of … MB Elshazly, SS Martin, MJ Blaha, PH Joshi, PP Toth, JW McEvoy, ... Journal of the American College of Cardiology 62 (21), 1960-1965, 2013 | 64 | 2013 |
| Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes D Clark III, SJ Nicholls, J St. John, MB Elshazly, SR Kapadia, EM Tuzcu, ... European heart journal 39 (27), 2551-2558, 2018 | 50 | 2018 |
| Warfarin use is associated with progressive coronary arterial calcification: insights from serial intravascular ultrasound J Andrews, PJ Psaltis, O Bayturan, M Shao, B Stegman, M Elshazly, ... JACC: Cardiovascular Imaging 11 (9), 1315-1323, 2018 | 49 | 2018 |
| Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation E Donnellan, P Aagaard, M Kanj, W Jaber, M Elshazly, M Hoosien, ... JACC: Clinical Electrophysiology 5 (8), 897-903, 2019 | 46 | 2019 |
| Accuracy of low-density lipoprotein cholesterol estimation at very low levels R Quispe, A Hendrani, MB Elshazly, ED Michos, JW McEvoy, MJ Blaha, ... BMC medicine 15 (1), 1-11, 2017 | 43 | 2017 |
| Very large database of lipids: rationale and design SS Martin, MJ Blaha, PP Toth, PH Joshi, JW McEvoy, HM Ahmed, ... Clinical cardiology 36 (11), 641-648, 2013 | 42 | 2013 |
| Visit-to-visit blood pressure variability, coronary atheroma progression, and clinical outcomes D Clark, SJ Nicholls, J St John, MB Elshazly, HM Ahmed, H Khraishah, ... JAMA cardiology 4 (5), 437-443, 2019 | 37 | 2019 |
| Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison with Low-Density Lipoprotein … MB Elshazly, R Quispe, ED Michos, AD Sniderman, PP Toth, M Banach, ... Circulation 132 (8), 667-676, 2015 | 37 | 2015 |
| Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation E Donnellan, OM Wazni, M Kanj, B Baranowski, P Cremer, S Harb, ... EP Europace 21 (10), 1476-1483, 2019 | 36 | 2019 |
| Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies E Donnellan, OM Wazni, M Hanna, MB Elshazly, R Puri, W Saliba, M Kanj, ... Clinical Electrophysiology 6 (9), 1118-1127, 2020 | 34 | 2020 |
| High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study R Quispe, ED Michos, SS Martin, R Puri, PP Toth, J Al Suwaidi, M Banach, ... Journal of the American Heart Association 9 (3), e013600, 2020 | 34 | 2020 |
| Impact of atrial fibrillation on exercise capacity and mortality in heart failure with preserved ejection fraction: insights from cardiopulmonary stress testing MB Elshazly, T Senn, Y Wu, B Lindsay, W Saliba, O Wazni, L Cho Journal of the American Heart Association 6 (11), e006662, 2017 | 33 | 2017 |
| Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease MB Elshazly, P Mani, S Nissen, DM Brennan, D Clark, S Martin, SR Jones, ... European Journal of Preventive Cardiology 27 (10), 1091-1100, 2020 | 30 | 2020 |
| No association between CHADS-VASc score and left atrial appendage thrombus in patients with transthyretin amyloidosis E Donnellan, MB Elshazly, S Vakamudi, OM Wazni, JA Cohen, M Kanj, ... JACC: Clinical Electrophysiology 5 (12), 1473-1474, 2019 | 28 | 2019 |
| Impact of novel low-density lipoprotein-cholesterol assessment on the utility of secondary non-high-density lipoprotein-C and apolipoprotein B targets in selected worldwide … V Sathiyakumar, J Park, R Quispe, MB Elshazly, ED Michos, M Banach, ... Circulation 138 (3), 244-254, 2018 | 27 | 2018 |
| Coronary atheroma progression rates in men and women following high-intensity statin therapy: a pooled analysis of REVERSAL, ASTEROID and SATURN B Stegman, M Shao, SJ Nicholls, M Elshazly, L Cho, P King, S Kapadia, ... Atherosclerosis 254, 78-84, 2016 | 27 | 2016 |
Seth S. Martin, MD, MHS, FACC, FAH...Associate Professor, Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular DiseaseVerified email at jhmi.edu
